Kyverna Therapeutics, Inc. is a California-based biopharmaceutical company. It lobbied Congress about health issues, specifically outreach regarding cell therapies for autoimmune diseases. The filings show one disclosure and no reported lobbying spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ADAM STEINMETZ
The latest disclosures for this client.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
EMILY FELDER
BROWNSTEIN HYATT FARBER SCHRECK, LLP
ms LAUREN ALEXANDRA MISH
BROWNSTEIN HYATT FARBER SCHRECK, LLP
STEPHEN HOLLAND
BROWNSTEIN HYATT FARBER SCHRECK, LLP